EUVIMEDEUVIMED entdecken
Crossref

Targeting FOSL2 via knockdown: a druggable strategy for protecting against hepatic ischemia/reperfusion injury through ATF4 suppression

Zexin Li, Xiao Wang, Yuanyuan Cui, Rui Wei, Yixin Wang, Yi Liu, Lifang Li, Jiasai Li, Liangbin Li, Keqiang Zuo

Biochemical Pharmacology · 2026-07 · 249 · 117908

DOI: 10.1016/j.bcp.2026.117908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-07. Verfasst von Zexin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Huaihe Hospital of Henan University, Kaifeng, Henan, China. Electronic address: lizexin403@henu.edu.cn. Hauptthemen laut MEDLINE: Reperfusion Injury, Fos-Related Antigen-2, Activating Transcription Factor 4, Liver. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Key Scientific Research Project of Colleges and Universities in Henan Province, Henan University, Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophage-mediated inflammatory response is a critical pathogenic component in hepatic ischemia/reperfusion injury (HIRI) development. Although FOS-like antigen 2 (FOSL2) plays a pivotal role in regulating macrophage polarization, its role and potential mechanisms in HIRI remain unclear. The findings demonstrated that FOSL2 exhibited elevated expression levels in both the liver tissues and macrophages of the liver tissues in IR rats. Knockdown of FOSL2 significantly alleviated HIRI-induced liver injury, accompanied by the suppression of hepatic tissue apoptosis and oxidative stress. Furthermore, FOSL2 knockdown led to a reduction in the pro-inflammatory M1 phenotype and an increase in the anti-inflammatory M2 phenotype of Kupffer cells (KCs). Concomitantly, FOSL2 expression was markedly upregulated in KCs following lipopolysaccharide (LPS) stimulation, and FOSL2 silencing potently promoted the phenotypic switch of KCs from the pro-inflammatory M1 to the anti-inflammatory M2 state. Additionally, knockdown of FOSL2 in KCs attenuated KC-induced hepatocyte apoptosis and oxidative stress. Transcriptomic analysis conducted on liver tissues from HIRI rats with or without FOSL2 knockdown identified a significant downregulation of activating transcription factor 4 (ATF4), with a log2 fold change of -1.51 and a p-value < 0.05. Mechanistically, FOSL2 bound to the promoter region of ATF4 to drive its transcription, and ATF4 overexpression abrogated the phenotypic and functional effects elicited by FOSL2 silencing. Collectively, our findings illustrate that FOSL2 knockdown exerts a protective role against IR-induced hepatic stress, highlighting the importance of FOSL2 as a potential therapeutic target for HIRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryFos-Related Antigen-2Activating Transcription Factor 4LiverAnimalsMaleRatsKupffer CellsGene Knockdown TechniquesRats, Sprague-DawleyOxidative StressApoptosis

Stichwörter der Autor:innen

FOSL2Hepatic ischemia/reperfusion injuryKupffer cellsTranscriptionTranscriptomics

Substanzen

Fos-Related Antigen-2Activating Transcription Factor 4Fosl2 protein, ratAtf4 protein, rat

Autor:innen und Institutionen

  • Department of General Surgery, Huaihe Hospital of Henan University, Kaifeng, Henan, China. Electronic address: lizexin403@henu.edu.cn.
  • School of Pharmacy, Henan Medical University, Xinxiang, Henan, China.
  • Department of Pathology, The First Affiliated Hospital of Henan Medical University, Xinxiang, Henan, China.
  • Translational Medicine Center, Huaihe Hospital of Henan University, Kaifeng, Henan, China.
  • Department of Plastic and Cosmetic Surgery, The First Affiliated Hospital of Henan Medical University, Xinxiang, Henan, China.
  • Department of General Surgery, The First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, Henan, China.

Förderung

  • Key Scientific Research Project of Colleges and Universities in Henan Province
  • Henan University
  • Natural Science Foundation of Henan Province

Zitieren

APA

Li, Z., Wang, X., Cui, Y., Wei, R., Wang, Y., Liu, Y., Li, L., Li, J., Li, L., & Zuo, K. (2026). Targeting FOSL2 via knockdown: a druggable strategy for protecting against hepatic ischemia/reperfusion injury through ATF4 suppression. Biochemical Pharmacology, 249, 117908. https://doi.org/10.1016/j.bcp.2026.117908

Vancouver

Li Z, Wang X, Cui Y, Wei R, Wang Y, Liu Y, et al. Targeting FOSL2 via knockdown: a druggable strategy for protecting against hepatic ischemia/reperfusion injury through ATF4 suppression. Biochemical Pharmacology. 2026;249:117908. doi:10.1016/j.bcp.2026.117908

BibTeX
@article{Li2026,
  author = {Li, Zexin and Wang, Xiao and Cui, Yuanyuan and Wei, Rui and Wang, Yixin and Liu, Yi and Li, Lifang and Li, Jiasai and Li, Liangbin and Zuo, Keqiang},
  title = {Targeting FOSL2 via knockdown: a druggable strategy for protecting against hepatic ischemia/reperfusion injury through ATF4 suppression},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {249},
  pages = {117908},
  doi = {10.1016/j.bcp.2026.117908}
}
Kostenlos starten →